The rest period between chemotherapy and immunotherapy influences the efficacy of immune checkpoint inhibitors in lung cancer

BACKGROUND: The use of immune checkpoint inhibitors (ICIs) as first‐line treatment rather than as second‐line treatment makes a big difference in the drug efficacy and progression‐free survival. However, the mechanism for this is still not clear. This study aimed to analyze the effects of the rest p...

Descripción completa

Detalles Bibliográficos
Autores principales: Kang, Da Hyun, Choi, Seong‐woo, Sun, Pureum, Chung, Chaeuk, Park, Dongil, Lee, Song‐I, Koh, Jeong Suk, Kim, Yoonjoo, Lee, Jeong Eun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9376175/
https://www.ncbi.nlm.nih.gov/pubmed/35818294
http://dx.doi.org/10.1111/1759-7714.14568

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9376175/
https://www.ncbi.nlm.nih.gov/pubmed/35818294
http://dx.doi.org/10.1111/1759-7714.14568

Ejemplares similares